BioSpace News Archive

Progenity, a biotechnology company with an established track record of success in developing and commercializing molecular testing products, has released four posters for the 2020 American College of Medical Genetics and Genomics’ Annual Clinical Genetics Meeting, which has transitioned to a Digital Edition platform in order to ensure the health and safety of registered attendees.

HORIZON, a lab information management system software and services company, is working with clinical data exchange and business intelligence provider Halfpenny Technologies Inc. to speed COVID-19 testing and results delivery through Accumen Inc.'s COVID-19 Regional Test Capacity and Routing Network, launched May 6, 2020.

ADVANZ PHARMA Corp. Limited (“ADVANZ PHARMA” or “the Company”), a global pharmaceutical company focused on serving the needs of patients and healthcare providers around the world with enhanced access to high quality, niche-established medicines, today announced that it closed its previously announced acquisition of specialty pharmaceutical company Correvio Pharma Corp. (“Correvio”) (NASDAQ: CORV) (TSX: CORV).

Tampa General Hospital’s top infection prevention experts are consulting with leading organizations in Tampa Bay and beyond to help them keep employees, customers and visitors safer from COVID-19 and other infectious diseases

Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Jefferies 2020 Virtual Healthcare Conference on Thursday, June 4, 2020, at approximately 9:00 a.m. (ET).

Trinity Life Sciences, a leader in global life sciences solutions, found that the majority of in-depth discussions at last week’s virtual TGaS Spring Summit focused on how pharmaceutical companies’ commercial operations need to adjust in response to the current pandemic.

Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), today announced the closing of its initial public offering of 9,432,949 shares of its common stock, including the exercise in full of the underwriters’ option to purchase 1,230,384 additional shares of common stock, at the initial public offering price of $19.00 per share

MedMira Inc. (MedMira) (TSXV: MIR) announces that company has entered into an Exclusive Distribution Agreement with Webb Diagnostic Technologies, Inc., (WebbDX) for the distribution of MedMira’s REVEALCOVID-19™ Total Antibody Test.

Loan taken out with Banque Populaire du Sud and BNP Paribas in the form of PGE

EarlySense, the global leader in contact-free, continuous monitoring solutions for the healthcare continuum, announced it is one of the strategic medical technologies chosen by Sheba Medical Center for their new COVID-19 inspired immersive simulation patient room of the future.